Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 1;82(1):37-39.
doi: 10.1097/FJC.0000000000001431.

Ginsenoside Re: Are we Close to a Safer Antiplatelet Therapy?

Matteo Betti  1   2 , Marco Bernardi  3 , Giampaolo Niccoli  4   5 , Giuseppe Biondi-Zoccai  6   7 , Luigi Spadafora  3
Affiliations

Ginsenoside Re: Are we Close to a Safer Antiplatelet Therapy?

Matteo Betti et al. J Cardiovasc Pharmacol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Giuseppe Biondi-Zoccai has consulted for Amarin, Balmed, Cardionovum, Crannmedical, Endocore Lab, Eukon, Innovheart, Guidotti, Meditrial, Microport, Opsens Medical, Replycare, Teleflex, and Terumo. All other authors report no conflict of interest.

References

    1. Passacquale G, Sharma P, Perera D, Ferro A. Antiplatelet therapy in cardiovascular disease: current status and future directions. Br J Clin Pharmacol. 2022;88:2686–2699.
    1. Gelbenegger G, Jilma B. Clinical pharmacology of antiplatelet drugs. Expert Rev Clin Pharmacol. 2022;15:1177–1197.
    1. Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114:774–782.
    1. Costa F, van Klaveren D, James S, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389:1025–1034.
    1. Tscharre M, Michelson AD, Gremmel T. Novel antiplatelet agents in cardiovascular disease. J Cardiovasc Pharmacol Ther. 2020;25:191–200.

MeSH terms